Current and Future Trial Design in Refractory Cardiogenic Shock
Mattia Arrigo(University Hospital of Zurich), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), David A. Baran(Cleveland Clinic), Antoni Bayés‐Genís(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Ovidiu Chioncel(Carol Davila University of Medicine and Pharmacy), Janine Poess(Leipzig Heart Institute), Andrew Morley‐Smith(Guy's and St Thomas' NHS Foundation Trust), Mahir Karakas(Universität Hamburg), Uwe Zeymer(University of Freiburg), Steffen Desch(Leipzig Heart Institute), Jacob Eifer Møller(University of Southern Denmark), Alice Blet(Inserm), Nadia Aïssaoui(Université Paris Cité), Susanna Price(Royal Brompton Hospital)
Cited by 5
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
|New England Journal of Medicine|2012|2.8k
Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
|New England Journal of Medicine|2013|2.8k